04Any false information provided within the context of the Excellence in Quality Award by any entity concerning identity, mailing address, telephone number, email address, ownership of right, or non-compliance with these rules or any terms and conditions or the like may result in the immediate elimination of the entity from the Awards process. 03Participation in the Excellence in Quality Award is voluntary.02The facility should be for the manufacturing of finished dosage formulations, located in India, serving the Indian patients and could be catering to the exports.i.e., either Large Pharma companies or MSME. 01The company/applicant can apply for any one category.There is a specification for each pharma dosage form and there is also a quality specification for each therapy area product that they must comply with to be able to assert that the products meet quality specifications. The Excellent facility Award is instituted by OPPI to align on the importance of setting and adopting best -in class global quality standards for the pharmaceutical industry. With this award we aim to recognize efforts by manufacturing enterprises for implementing innovative manufacturing systems led to development of quality culture in the Indian pharmaceutical sector. OPPI believes that it is imperative for the industry to build a quality culture in the country and provide medicines with global quality standards to the patients. This is a critical component in any industry but especially in the pharmaceutical industry, where patient safety is paramount. Pharmaceutical industry participants as well as regulatory authorities have always prioritised Good Manufacturing Practices (GMP). The COVID-19 pandemic has highlighted the importance of high-quality products with a reliable supply chain.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |